Chronic administration of ethanol leads to an increased incidence of hepatocellular adenoma by promoting H-ras-mutated cells

Cancer Letters

Volumn 301, Issue 2, 2011, Pages 161-167

  Jeannot, Emmanuelle ^a   Pogribny, Igor P ^b   Beland, Frederick A ^b   Rusyn, Ivan ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Catenin; Alcohol; H ras; HNF1 ; Liver tumors

Indexed keywords

ALCOHOL; DRINKING WATER;

ALCOHOL METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B6C3F1 MOUSE; CANCER INCIDENCE; CONTROLLED STUDY; DRINKING BEHAVIOR; GENE MUTATION; LIVER ADENOMA; LIVER CARCINOGENESIS; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; ONCOGENE H RAS; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADENOMA, LIVER CELL; ANIMALS; BETA CATENIN; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; GENE FREQUENCY; HEPATITIS, ALCOHOLIC; IMMUNOHISTOCHEMISTRY; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, INBRED STRAINS; MUTAGENESIS; OXIDATIVE STRESS; PROLIFERATING CELL NUCLEAR ANTIGEN; RAS PROTEINS; TIME FACTORS;

MUS;

EID: 78651450811     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2010.11.010     Document Type: Article

References (52)

1. Rehm J., Room R., Monteiro M., Gmel G., Graham K., Rehn N., Sempos C.T., Frick U., Jernigan D. Alcohol use. Comparative Quantification of Health Risks. Global and Regional Burden of Disease Attributable to Selected Major Risk Factors 2004, 960-1108. WHO, Geneva. M. Ezzati, A. Lopez, A. Rodgers, C. Murray (Eds.).
2. International Agency for Research on Cancer, Alcohol Drinking, World Health Organization, IARC, Lyon, France, 1988.
3. National Toxicology Program, Toxicology and Carcinogenesis Studies of Urethane, Ethanol, and Urethane/Ethanol (Urethane, CAS No. 51-79-6; Ethanol, CAS No. 64-17-5) in B6C3F1 Mice (Drinking Water Studies), Natl. Toxicol. Program Tech. Rep. Ser., 2004, pp. 1-346.
4. Baan R., Straif K., Grosse Y., Secretan B., el Ghissassi F., Bouvard V., Altieri A., Cogliano V. Carcinogenicity of alcoholic beverages. Lancet Oncol. 2007, 8:292-293.
5. Breitkopf K., Nagy L.E., Beier J.I., Mueller S., Weng H., Dooley S. Current experimental perspectives on the clinical progression of alcoholic liver disease. Alcohol Clin. Exp. Res. 2009, 33:1647-1655.
6. Seitz H.K., Stickel F. Alcoholic liver disease in the elderly. Clin. Geriatr. Med. 2007, 23:905-921. viii.
7. Seitz H.K., Stickel F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat. Rev. Cancer 2007, 7:599-612.
8. Anderson L.M. Increased numbers of N-nitrosodimethylamine-initiated lung tumors in mice by chronic co-administration of ethanol. Carcinogenesis 1988, 9:1717-1719.
9. Wendt L.R., Osvaldt A.B., Bersch V.P., Schumacher R.C., Edelweiss M.I., Rohde L. Pancreatic intraepithelial neoplasia and ductal adenocarcinoma induced by DMBA in mice: effects of alcohol and caffeine. Acta Cir. Bras. 2007, 22:202-209.
10. Kushida M., Wanibuchi H., Morimura K., Kinoshita A., Kang J.S., Puatanachokchai R., Wei M., Funae Y., Fukushima S. Dose-dependence of promotion of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline-induced rat hepatocarcinogenesis by ethanol: evidence for a threshold. Cancer Sci. 2005, 96:747-757.
11. Chen M., Huang J.D., Hu L., Zheng B.J., Chen L., Tsang S.L., Guan X.Y. Transgenic CHD1L expression in mouse induces spontaneous tumors. PLoS One 2009, 4:e6727.
12. Beland F.A., Benson R.W., Mellick P.W., Kovatch R.M., Roberts D.W., Fang J.L., Doerge D.R. Effect of ethanol on the tumorigenicity of urethane (ethyl carbamate) in B6C3F1 mice. Food Chem. Toxicol. 2005, 43:1-19.
13. Watabiki T., Okii Y., Tokiyasu T., Yoshimura S., Yoshida M., Akane A., Shikata N., Tsubura A. Long-term ethanol consumption in ICR mice causes mammary tumor in females and liver fibrosis in males. Alcohol Clin. Exp. Res. 2000, 24:117S-122S.
14. Soffritti M., Belpoggi F., Cevolani D., Guarino M., Padovani M., Maltoni C. Results of long-term experimental studies on the carcinogenicity of methyl alcohol and ethyl alcohol in rats. Ann. New York Acad. Sci. 2002, 982:46-69.
15. Zakhari S. Overview: how is alcohol metabolized by the body?. Alcohol Res. Health 2006, 29:245-254.
16. Lu Y., Cederbaum A.I. CYP2E1 and oxidative liver injury by alcohol. Free Radic. Biol. Med. 2008, 44:723-738.
17. McKillop I.H., Schrum L.W. Role of alcohol in liver carcinogenesis. Semin. Liver Dis. 2009, 29:222-232.
18. Bradford B.U., Kono H., Isayama F., Kosyk O., Wheeler M.D., Akiyama T.E., Bleye L., Krausz K.W., Gonzalez F.J., Koop D.R., Rusyn I. Cytochrome P450 CYP2E1, but not nicotinamide adenine dinucleotide phosphate oxidase, is required for ethanol-induced oxidative DNA damage in rodent liver. Hepatology 2005, 41:336-344.
19. Secretan B., Straif K., Baan R., Grosse Y., el Ghissassi F., Bouvard V., Benbrahim-Tallaa L., Guha N., Freeman C., Galichet L., Cogliano V. A review of human carcinogens - part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol. 2009, 10:1033-1034.
20. Brooks P.J., Theruvathu J.A. DNA adducts from acetaldehyde: implications for alcohol-related carcinogenesis. Alcohol 2005, 35:187-193.
21. Masalkar P.D., Abhang S.A. Oxidative stress and antioxidant status in patients with alcoholic liver disease. Clin. Chim. Acta 2005, 355:61-65.
22. Millonig G., Wang Y., Homann N., Bernhardt F., Qin H., Mueller S., Bartsch H., Seitz H.K. Ethanol-mediated carcinogenesis in the human esophagus implicates CYP2E1 induction and the generation of carcinogenic DNA-lesions. Int. J. Cancer 2010.
23. Tsuchiya M., Kono H., Matsuda M., Fujii H., Rusyn I. Protective effect of Juzen-taiho-to on hepatocarcinogenesis is mediated through the inhibition of Kupffer cell-induced oxidative stress. Int. J. Cancer 2008, 123:2503-2511.
24. Strauss W.M. Preparation of genomic DNA from mammalian tissue. Current Protocols in Molecular Biology 1989, 2.2.1-2.2.3. Wiley-Interscience, New-York. F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.A. Seidman, J.A. Smith, K. Struhl (Eds.).
25. Mitchell K.R., Warshawsky D. Mutational analysis using enriched PCR and cycle sequencing. Biotechniques 1998, 24:1028-1031.
26. Bioulac-Sage P., Rebouissou S., Thomas C., Blanc J.F., Saric J., Sa C.A., Rullier A., Cubel G., Couchy G., Imbeaud S., Balabaud C., Zucman-Rossi J. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 2007, 46:740-748.
27. Cariello N.F., Piegorsch W.W., Adams W.T., Skopek T.R. Computer program for the analysis of mutational spectra: application to p53 mutations. Carcinogenesis 1994, 15:2281-2285.
28. Lieber C.S., DeCarli L.M. The feeding of alcohol in liquid diets: two decades of applications and 1982 update. Alcohol Clin. Exp. Res. 1982, 6:523-531.
29. Tsukamoto H., French S.W., Benson N., Delgado G., Rao G.A., Larkin E.C., Largman C. Severe and progressive steatosis and focal necrosis in rat liver induced by continuous intragastric infusion of ethanol and low fat diet. Hepatology 1985, 5:224-232.
30. Mansouri A., Gaou I., De Kerguenec C., Amsellem S., Haouzi D., Berson A., Moreau A., Feldmann G., Letteron P., Pessayre D., Fromenty B. An alcoholic binge causes massive degradation of hepatic mitochondrial DNA in mice. Gastroenterology 1999, 117:181-190.
31. Abraham P., Wilfred G., Ramakrishna B. Oxidative damage to the hepatocellular proteins after chronic ethanol intake in the rat. Clin. Chim. Acta 2002, 325:117-125.
32. Puzziferri I., Signorile A., Guerrieri F., Papa S., Cuomo V., Steardo L. Chronic low dose ethanol intake: biochemical characterization of liver mitochondria in rats. Life Sci. 2000, 66:477-484.
33. Navasumrit P., Ward T.H., O'Connor P.J., Nair J., Frank N., Bartsch H. Ethanol enhances the formation of endogenously and exogenously derived adducts in rat hepatic DNA. Mutat. Res. 2001, 479:81-94.
34. Sills R.C., Boorman G.A., Neal J.E., Hong H.L., Devereux T.R. Mutations in ras genes in experimental tumours of rodents. The Use of Short- and Medium-term Tests for Carcinogens and Data on Genetic Effects in Carcinogenic Hazard Evaluation 1999, 55-86. International Agency for Research on Cancer, Lyon, France. D.B. McGregor, J.M. Rice, S. Venitt (Eds.).
35. Bluteau O., Jeannot E., Bioulac-Sage P., Marques J.M., Blanc J.F., Bui H., Beaudoin J.C., Franco D., Balabaud C., Laurent-Puig P., Zucman-Rossi J. Bi-allelic inactivation of TCF1 in hepatic adenomas. Nat. Genet. 2002, 32:312-315.
36. Marnett L.J. Oxyradicals and DNA damage. Carcinogenesis 2000, 21:361-370.
37. Kim Y.D., Eom S.Y., Ogawa M., Oyama T., Isse T., Kang J.W., Zhang Y.W., Kawamoto T., Kim H. Ethanol-induced oxidative DNA damage and CYP2E1 expression in liver tissue of Aldh2 knockout mice. J. Occup. Health 2007, 49:363-369.
38. Gao D., Wei C., Chen L., Huang J., Yang S., Diehl A.M. Oxidative DNA damage and DNA repair enzyme expression are inversely related in murine models of fatty liver disease. Am. J. Physiol. Gastroint. Liver Physiol. 2004, 287:G1070-G1077.
39. Cahill A., Wang X., Hoek J.B. Increased oxidative damage to mitochondrial DNA following chronic ethanol consumption. Biochem. Biophys. Res. Commun. 1997, 235:286-290.
40. Assuncao M., Santos-Marques M.J., Monteiro R., Azevedo I., Andrade J.P., Carvalho F., Martins M.J. Red wine protects against ethanol-induced oxidative stress in rat liver. J. Agric. Food Chem. 2009, 57:6066-6073.
41. Rusyn I., Asakura S., Pachkowski B., Bradford B.U., Denissenko M.F., Peters J.M., Holland S.M., Reddy J.K., Cunningham M.L., Swenberg J.A. Expression of base excision DNA repair genes is a sensitive biomarker for in vivo detection of chemical-induced chronic oxidative stress: identification of the molecular source of radicals responsible for DNA damage by peroxisome proliferators. Cancer Res. 2004, 64:1050-1057.
42. Anderson M., Stanley L., Devereux T., Reynolds S., Maronpot R. Oncogenes in mouse liver tumors. Prog. Clin. Biol. Res. 1992, 376:187-201.
43. Bauer-Hofmann R., Buchmann A., Mahr J., Kress S., Schwarz M. The tumour promoters dieldrin and phenobarbital increase the frequency of c-Ha-ras wild-type, but not of c-Ha-ras mutated focal liver lesions in male C3H/He mice. Carcinogenesis 1992, 13:477-481.
44. Ferreira-Gonzalez A., Deangelo A.B., Nasim S., Garrett C.T. Ras oncogene activation during hepatocarcinogenesis in B6C3F1 male mice by dichloroacetic and trichloroacetic acids. Carcinogenesis 1995, 16:495-500.
45. Devereux T.R., Foley J.F., Maronpot R.R., Kari F., Anderson M.W. Ras proto-oncogene activation in liver and lung tumors from B6C3F1 mice exposed chronically to methylene chloride. Carcinogenesis 1993, 14:795-801.
46. Watson M.A., Devereux T.R., Malarkey D.E., Anderson M.W., Maronpot R.R. H-ras oncogene mutation spectra in B6C3F1 and C57BL/6 mouse liver tumors provide evidence for TCDD promotion of spontaneous and vinyl carbamate-initiated liver cells. Carcinogenesis 1995, 16:1705-1710.
47. Fox T.R., Schumann A.M., Watanabe P.G., Yano B.L., Maher V.M., McCormick J.J. Mutational analysis of the H-ras oncogene in spontaneous C57BL/6 x C3H/He mouse liver tumors and tumors induced with genotoxic and nongenotoxic hepatocarcinogens. Cancer Res. 1990, 50:4014-4019.
48. Maronpot R.R., Fox T., Malarkey D.E., Goldsworthy T.L. Mutations in the ras proto-oncogene: clues to etiology and molecular pathogenesis of mouse liver tumors. Toxicology 1995, 101:125-156.
49. Tward A.D., Jones K.D., Yant S., Cheung S.T., Fan S.T., Chen X., Kay M.A., Wang R., Bishop J.M. Distinct pathways of genomic progression to benign and malignant tumors of the liver. Proc. Natl. Acad. Sci. USA 2007, 104:14771-14776.
50. Zucman-Rossi J., Jeannot E., Nhieu J.T., Scoazec J.Y., Guettier C., Rebouissou S., Bacq Y., Leteurtre E., Paradis V., Michalak S., Wendum D., Chiche L., Fabre M., Mellottee L., Laurent C., Partensky C., Castaing D., Zafrani E.S., Laurent-Puig P., Balabaud C., Bioulac-Sage P. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 2006, 43:515-524.
51. Bosetti C., Levi F., Lucchini F., Zatonski W.A., Negri E., La Vecchia C. Worldwide mortality from cirrhosis: an update to 2002. J. Hepatol. 2007, 46:827-839.
52. Jeannot E., Mellottee L., Bioulac-Sage P., Balabaud C., Scoazec J.Y., Tran V.N., Bacq Y., Michalak S., Buob D., Laurent-Puig P., Rusyn I., Zucman-Rossi J. Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damage. Diabetes 2010, 59:1836-1844.